Adhera Therapeutics Inc ATRX:OTCPK

RT Quote | Exchange | USD
Last | 03/05/21 EST
0.12UNCH (UNCH)
Volume
45,152
52 week range
0.01 - 0.30

...

Loading . . .

KEY STATS

  • Open0.12
  • Day High0.12
  • Day Low0.09
  • Prev Close0.12
  • 52 Week High0.30
  • 52 Week High Date06/10/20
  • 52 Week Low0.01
  • 52 Week Low Date12/23/20
  • Market Cap1.30M
  • Shares Out10.87M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.88
  • 1 Year % Change140

RATIOS/PROFITABILITY

  • EPS (TTM)-0.81
  • P/E (TTM)-0.15
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-4.493M
  • ROE (MRQ)-3,578.88%
  • Revenue (MRQ)130,000.00
  • Gross Margin (MRQ)20.45%
  • Net Margin (MRQ)-5,581.06%
  • Debt To Equity (MRQ)-44.59%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Adhera Therapeutics Inc News

There is no recent news for this security.

Latest ATRX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Adhera Therapeutics, Inc., formerly Marina Biotech, Inc., is a specialty pharmaceutical company that provides patient centric treatment for hypertension. The Company develops and commercializes pharmaceutical therapies and provides technology to improve patient outcomes. It is also focused on developing and commercializing late-stage, non-addictive pain therapeutics. It provides Celecoxib-Lisinopril fixed dose combination (IT-102) and Celecoxib-Olmesartan fixed dose...
Andrew Kucharchuk
Chief Executive Officer
Address
P.O. Box 2161
Wake Forest, NC
27588
United States